Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Idrugs : the Investigational Drugs Journal|October 4, 2005
IL-6 and arthritis: a detrimental or beneficial mediator?H Tilg, A Kaser
Gut|September 14, 2004
Diet and relapsing ulcerative colitis: take off the meat?H Tilg, A Kaser
The New England Journal of Medicine|November 18, 2000
Cytokines in alcoholic and nonalcoholic steatohepatitisH Tilg, A M Diehl
International Journal of Colorectal Disease|January 28, 2003
Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseasesO Ludwiczek, A Kaser, H Tilg
Deutsche Medizinische Wochenschrift (1946)|May 8, 1992
[Does the determination of serum neopterin secure blood transfusion?]A Wilmer, H Tilg, W Vogel
Journal of Hepatology|September 17, 1999
Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alphaA Kaser, W Vogel, H Tilg
Cytokine|October 20, 1999
Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expressionA Kaser, S Nagata, H Tilg
Cytokine|March 26, 1998
Differential regulation of interleukin 4 and interleukin 13 production by interferon alphaA Kaser, C Molnar, H Tilg
International Journal of Clinical Practice|June 30, 2010
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver diseaseS Kaser, C F Ebenbichler, H Tilg
Blood|January 15, 1995
Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humansH Tilg, W Vogel, C A Dinarello
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Idrugs : the Investigational Drugs Journal|October 4, 2005
IL-6 and arthritis: a detrimental or beneficial mediator?H Tilg, A Kaser
Gut|September 14, 2004
Diet and relapsing ulcerative colitis: take off the meat?H Tilg, A Kaser
The New England Journal of Medicine|November 18, 2000
Cytokines in alcoholic and nonalcoholic steatohepatitisH Tilg, A M Diehl
International Journal of Colorectal Disease|January 28, 2003
Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseasesO Ludwiczek, A Kaser, H Tilg
Deutsche Medizinische Wochenschrift (1946)|May 8, 1992
[Does the determination of serum neopterin secure blood transfusion?]A Wilmer, H Tilg, W Vogel
Journal of Hepatology|September 17, 1999
Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alphaA Kaser, W Vogel, H Tilg
Cytokine|October 20, 1999
Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expressionA Kaser, S Nagata, H Tilg
Cytokine|March 26, 1998
Differential regulation of interleukin 4 and interleukin 13 production by interferon alphaA Kaser, C Molnar, H Tilg
International Journal of Clinical Practice|June 30, 2010
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver diseaseS Kaser, C F Ebenbichler, H Tilg
Blood|January 15, 1995
Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humansH Tilg, W Vogel, C A Dinarello
Pageof 15